Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Biology » Biology - General » Advances in Medicine and Biology. Volume 21 Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Fetal Alcohol Syndrome: Recognition, Differential Diagnosis and Long-Term Effects
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Vitamin K as a Ligand of Steroid and Xenobiotic Receptor pp. 209-216
Tell A Friend
Tell someone you know about this product.
Vitamin K as a Ligand of Steroid and Xenobiotic Receptor pp. 209-216 $0.00
Authors:  (Kotaro Azuma, Kuniko Horie-Inoue, Yasuyoshi Ouchi, Satoshi Inoue, University of Tokyo and Saitama Medical University, Japan)
Vitamin K is a fat-soluble vitamin essential for blood coagulation. Natural vitamin K includes vitamin K1 (phylloquinone), present mainly in vegetables, and vitamin K2 (menaquinone), which is synthesized by microorganisms and is present in food such as natto (fermented soy beans). Vitamin K1 is converted to vitamin K2, the functionally active form, in the body [1].
Vitamin K was shown to play an essential role in the hepatocytes by maintaining the activity of coagulation factors II, VII, IX, and X and of anticoagulants, protein C, and protein S. Recently, extrahepatic actions of vitamin K have also been reported. The administration of vitamin K was shown to prevent bone fracture [2, 3], and this led to its clinical application in cases of osteoporosis in East Asian countries. Epidemiological studies have shown that the lack of vitamin K causes osteoarthritis [4] and imposes a risk of coronary artery disease [5]. Some clinical studies have suggested its antitumor activity in cases of hepatocellular carcinoma [6-8] and other cancers [9].
Until recently, vitamin K was primarily known as a co-enzyme of γ-glutamyl carboxylase (GGCX), which converts glutamic acid (Glu) to γ-carboxyglutamic acid (Gla) during the post-transcriptional modification of proteins. During this reaction, vitamin K is oxidized from vitamin K hydroquinone to vitamin K epoxide. Thus far, the following 15 proteins are known to be the substrates of GGCX: coagulation factors II, VII, IX, and X; protein C; protein S; growth arrest specific-6 (Gas6) [10]; osteocalcin (also known as bone Gla protein [BGP]) [11]; matrix Gla protein (MGP) [12]; periostin [13]; Ig-H3 [13]; proline-rich Gla proteins 1 and 2 [14]; and transmembrane Gla proteins 3 and 4 [15]. Warfarin, which is clinically used as an anticoagulation drug, inhibits the activity of vitamin K epoxide reductase (VKOR). The lack of VKOR activity renders the GGCX-oxidized vitamin K useless, resulting in a decrease in the GGCX activity. 

Available Options:

  Open Access item.
  Click below PDF icon for free download.


This is an Open Access item. Click above PDF icon for free download.
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2021

Vitamin K as a Ligand of Steroid and Xenobiotic Receptor pp. 209-216